Given the increased presence of tumor-infiltrating activated/cytotoxic CD8 T-cells following CAR T-cell treatment, a role of M-MDSC in supporting or dampening the tumor responses to CAR T-cells needs to be further investigated. The gene discussed is CD8A; the disease is neoplasm.